SCHEMBL433887

SCHEMBL433887

O=C(O)CON=C1CCOc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.43
MAPK9 P45984 1/20 0.43
MAPK10 P53779 1/20 0.43
NOTUM Q6P988 1/20 0.39
MAPT P10636 3/20 0.37
RAB9A P51151 3/20 0.37
CYP3A4 P08684 2/20 0.37
NPC1 O15118 2/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
GRM5 P41594 1/20 0.35
CTNNB1 P35222 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11539890 0.79 NOTUM (0.47) NOTUMMAPTNPC1L3MBTL1ALDH1A1
SCHEMBL11539893 0.79 NOTUM (0.47) NOTUMMAPTNPC1L3MBTL1ALDH1A1
SCHEMBL12609459 0.78 NOTUM (0.43) NOTUMMAPTRAB9ACYP3A4NPC1
SCHEMBL17146135 0.75 MEN1 (0.40) NOTUMMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL10556400 0.75 MAPK8 (0.52) MAPK8MAPK9MAPK10MAPTPOLB
SCHEMBL13167842 0.75 MEN1 (0.40) NOTUMMAPTL3MBTL1ALDH1A1MEN1
SCHEMBL11540587 0.75 NOTUM (0.40) NOTUMMAPTRAB9ACYP3A4NPC1
SCHEMBL11539391 0.75 NOTUM (0.40) NOTUMMAPTRAB9ACYP3A4NPC1
SCHEMBL11540152 0.75 LMNA (0.41) NOTUMMAPTRAB9ACYP3A4NPC1
SCHEMBL11540155 0.75 LMNA (0.41) NOTUMMAPTRAB9ACYP3A4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4108873-A O-(carboxymethyl)-4-chromanone oxime MORTON-NORWICH PRODUCTS, INC. (US) 1978-08-22 US claimed
US-9642854-B2 Flavanoid compounds and process for preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-05-09 US disclosed
US-20150174135-A1 FLAVANOID COMPOUNDS AND PROCESS FOR PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2015-06-25 US disclosed
US-20120022062-A1 Flavanoid Compounds and Process for Preparation Thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-01-26 US disclosed
US-4108873-A O-(carboxymethyl)-4-chromanone oxime MORTON-NORWICH PRODUCTS, INC. (US) 1978-08-22 US disclosed
US-4108873-A O-(carboxymethyl)-4-chromanone oxime MORTON-NORWICH PRODUCTS, INC. (US) 1978-08-22 US disclosed
US-4108873-A O-(carboxymethyl)-4-chromanone oxime MORTON-NORWICH PRODUCTS, INC. (US) 1978-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150174135-A1 FLAVANOID COMPOUNDS AND PROCESS FOR PREPARATION THEREOF F2, FOXM1, HRH2 MAPK8 2690/4885MAPK9 2519/4885MAPK10 2133/4885
US-20120022062-A1 Flavanoid Compounds and Process for Preparation Thereof F2, FOXM1, HRH2 MAPK8 2690/4885MAPK9 2519/4885MAPK10 2133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.